Blocking the TNF-α pathway decreases central immune infiltration and prevents AD neurochemical and behavioral phenotypes (Tweedie et al., 2012; Prasad Gabbita et al., 2015), suggesting that central–peripheral cross-talk may be implicated in the disease. Here, TNF is linked to Alzheimer disease.